Steward Partners Investment Advisory’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.26M | Sell |
13,713
-395
| -3% | -$82.1K | 0.02% | 721 |
|
|
2026
Q1 | $2.98M | Buy |
14,108
+1,990
| +16% | +$429K | 0.02% | 703 |
|
|
2025
Q4 | $2.49M | Buy |
12,118
+188
| +2% | +$35.4K | 0.01% | 701 |
|
|
2025
Q3 | $1.87M | Buy |
11,930
+3,223
| +37% | +$498K | 0.01% | 802 |
|
|
2025
Q2 | $1.46M | Buy |
8,707
+228
| +3% | +$33.8K | 0.01% | 830 |
|
|
2025
Q1 | $1.17M | Sell |
8,479
-2,625
| -24% | -$335K | 0.01% | 859 |
|
|
2024
Q4 | $1.31M | Buy |
11,104
+7,930
| +250% | +$926K | 0.01% | 785 |
|
|
2024
Q3 | $351K | Sell |
3,174
-65
| -2% | -$6.8K | ﹤0.01% | 1265 |
|
|
2024
Q2 | $318K | Buy |
3,239
+480
| +17% | +$48.9K | ﹤0.01% | 1254 |
|
|
2024
Q1 | $309K | Buy |
2,759
+32
| +1% | +$3.45K | ﹤0.01% | 1247 |
|
|
2023
Q4 | $275K | Buy |
2,727
+746
| +38% | +$74K | ﹤0.01% | 1251 |
|
|
2023
Q3 | $172K | Sell |
1,981
-308
| -13% | -$27.8K | ﹤0.01% | 1358 |
|
|
2023
Q2 | $216K | Buy |
2,289
+126
| +6% | +$10.6K | ﹤0.01% | 1249 |
|
|
2023
Q1 | $163K | Sell |
2,163
-2,235
| -51% | -$169K | ﹤0.01% | 1374 |
|
|
2022
Q4 | $338K | Buy |
4,398
+242
| +6% | +$18.4K | 0.01% | 1037 |
|
|
2022
Q3 | $277K | Sell |
4,156
-118
| -3% | -$7.48K | 0.01% | 1062 |
|
|
2022
Q2 | $223K | Sell |
4,274
-293
| -6% | -$16.7K | ﹤0.01% | 1168 |
|
|
2022
Q1 | $259K | Buy |
4,567
+63
| +1% | +$3.37K | ﹤0.01% | 1193 |
|
|
2021
Q4 | $232K | Sell |
4,504
-873
| -16% | -$42.8K | ﹤0.01% | 1249 |
|
|
2021
Q3 | $266K | Buy |
5,377
+213
| +4% | +$11.6K | ﹤0.01% | 1148 |
|
|
2021
Q2 | $295K | Sell |
5,164
-729
| -12% | -$42.6K | 0.01% | 1197 |
|
|
2021
Q1 | $358K | Buy |
5,893
+831
| +16% | +$45.9K | 0.01% | 1021 |
|
|
2020
Q4 | $271K | Buy |
5,062
+99
| +2% | +$5.14K | 0.01% | 951 |
|
|
2020
Q3 | $233K | Sell |
4,963
-1,124
| -18% | -$57.7K | 0.01% | 891 |
|
|
2020
Q2 | $318K | Buy |
6,087
+24
| +0.4% | +$1.24K | 0.01% | 740 |
|
|
2020
Q1 | $290K | Sell |
6,063
-421
| -6% | -$21.9K | 0.01% | 681 |
|
|
2019
Q4 | $327K | Buy |
6,484
+252
| +4% | +$13K | 0.01% | 736 |
|
|
2019
Q3 | $294K | Sell |
6,232
-260
| -4% | -$11.9K | 0.01% | 731 |
|
|
2019
Q2 | $305K | Sell |
6,492
-265
| -4% | -$12.2K | 0.01% | 685 |
|
|
2019
Q1 | $325K | Sell |
6,757
-4,458
| -40% | -$223K | 0.01% | 620 |
|
|
2018
Q4 | $500K | Buy |
11,215
+1,634
| +17% | +$85.2K | 0.02% | 486 |
|
|
2018
Q3 | $517K | Buy |
9,581
+2,820
| +42% | +$144K | 0.02% | 493 |
|
|
2018
Q2 | $330K | Buy |
6,761
+5,291
| +360% | +$300K | 0.02% | 545 |
|
|
2018
Q1 | $92K | Buy |
1,470
+42
| +3% | +$2.88K | 0.01% | 804 |
|
|
2017
Q4 | $87K | Sell |
1,428
-107
| -7% | -$6.62K | 0.01% | 666 |
|
|
2017
Q3 | $102K | Sell |
1,535
-535
| -26% | -$37.8K | 0.01% | 540 |
|
|
2017
Q2 | $161K | Sell |
2,070
-320
| -13% | -$24.1K | 0.02% | 436 |
|
|
2017
Q1 | $194K | Buy |
+2,390
| New | +$188K | 0.03% | 327 |
|
Other funds holding CAH
Steward Partners Investment Advisory's CAH Position: Q2 2026 in Review
Steward Partners Investment Advisory reduced its Cardinal Health (CAH) stake by 2.8% in Q2 2026, selling an estimated $82.1K and leaving 13,713 shares worth $3.26M. The position accounts for 0.02% of the portfolio, ranked #721.
Steward Partners Investment Advisory first reported a position in CAH in Q1 2017 and has held it in 38 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Steward Partners Investment Advisory held 13,713 shares of Cardinal Health worth $3.26M as of Q2 2026.
- Steward Partners Investment Advisory sold 395 Cardinal Health shares in Q2 2026, an estimated $82.1K.
- Cardinal Health made up 0.02% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #721 holding.
- Steward Partners Investment Advisory first reported a position in Cardinal Health in Q1 2017 and has held it in 38 quarters since.
- 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.